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Abstract 
Sleep problems are common in people with low back pain (LBP), however the mechanisms on how 
sleep influences pain are complex. To date there is a lack of prospective research on the timings and 
the development of sleep problems in those who have LBP, such information would be useful to 
identify individuals at risk of poor outcome. Aims are to investigate the predictive role of sleep 
problems on self-report recovery and pain intensity using logistic regression reporting Odds Ratios 
(OR). An observational cohort of 761 chronic LBP patients recruited from a pain management clinic 
participated, and completed data at baseline, and at 6 month follow-up (n = 682). Results show an 
increased odds of reported non-recovery (OR 1.52) and pain intensity (OR 2.69) for those who report 
sleep problems at baseline. Further analysis on the experience of sleep problems through time show 
that those with developing sleep problems (i.e. no sleep problems at baseline but reported sleep 
problems at follow-up) were at increased odds of reporting non-recovery (OR 2.17) and pain intensity 
(OR 2.95), as was those who reported sleep problems at both baseline and follow-up, for recovery 
(OR 2.88), and pain intensity (OR 3.45). Those with resolving sleep problems (i.e. sleep problems 
present at baseline but not at follow-up) were at a decreased odds of non-recovery (OR 0.50) and 
pain intensity (0.49). Presenting, persistent, and developing sleep problems have a significant impact 
on recovery for those with LBP, clinicians may wish to consider treatment options that can address 
sleep problems. 
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Introduction 
 
Low back pain (LBP) is a common condition affecting most people at some point in their lives. A 
recent review of 165 studies from 54 countries report a point prevalence rate at 18%, 1 year 
prevalence rate of 38%, and a lifetime prevalence range of 40% to 80% 1. Recurrence of LBP is also 
common; a review of cohort studies report an estimated 70% recurrence rate over 5 years for those 
with LBP 2.  This has led LBP to have a significant global impact in terms of disability to the individual 
3,4
, and a significant financial impact; LBP patients have higher direct and indirect costs compared to 
other patient groups 5. 
Recently there has been a growth of research attention on the role of sleep, in particular sleep 
problems, and the effect this may have on the outcomes for those with LBP. Sleep problems 
associated with back pain are common, a large epidemiological study reported that over half of those 
who report back pain also reported sleep problems 6, and a review of 13 LBP studies report a 
prevalence rate of 58.9% for people ascribing sleep problems related to their back pain 7. The 
influence of pain on sleep, and vice versa, is complex and most likely reciprocal, with evidence of 
consistent associations between LBP and sleep initiation, sleep disturbance, sleep duration, sleep 
quality, EEG and polysomnography output, and poor daytime functioning 8-10. Studies have shown 
associations between increases in poor sleep quality and increased pain intensity 7, as well as 
experimental evidence of a lower pain threshold due to sleep disturbance 11, and increased risk of 
psychological morbidity (e.g. depression) due to sleep problems in those who report pain 12. Current 
thought on the association between sleep disturbance and pain suggests a key link is the relationship 
between sleep, fatigue, and psychological morbidity (depression, anxiety), leading to a potential 
compounding effect on pain perception, function and recovery 7,8,10. Indeed sleep problems are a 
diagnostic feature of depression, and therefore it is important to examine potential confounding effects 
12
. There are also inflammatory processes that associate with the sleep cycle that may modulate 
nociception 8. Evidence shows higher sleep disturbance are found within inflammatory populations 
(e.g. rheumatology and fibromyalgia populations) 13,14, and recent evidence on chronic LBP 
participants has shown changes in pro-inflammatory markers (Interluekin-6) linked to sleep 
disturbance 15.  
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However, to date prospective evidence is limited on the relationship between LBP and sleep 
problems. Little is known about the timings and sequences on the development of sleep problems in 
those with back pain, or the impact they have on recovery, something which is reflected within the 
wider field of pain research 9. Such information would be useful for clinicians to assist in the 
identification of individuals who may require additional interventions alongside usual pain 
management (e.g. sleep hygiene treatment). The primary aim of this current study was to examine the 
prospective predictive role of sleep problems associated with LBP patient self-report recovery and 
pain intensity outcomes. Secondary aims were to examine differences over time between LBP 
patients who have no sleep problems, and those with sleep problems, those who develop sleep 
problems over time, and those who have a reduction of sleep problems over time. In line with recent 
prospective evidence for the relationship between sleep and pain 9, it is hypothesised that, compared 
to those who do not report sleep problems, those with developing sleep problems will be less likely to 
report a favourable recovery, and that those with persistent sleep problems will have the worse 
outcomes overall. 
 
Methods 
This was a prospective study of patients with LBP, and was carried out between February 2014 and 
December 2014. Full ethical approval was granted by the Medical Ethics Committee at Qazvin 
University of Medical Sciences. 
 
The cohort was inclusive of a convenience sample of consecutive patients with LBP attending the 
Outpatient Chronic Pain Clinic, Department of the Neurosurgery, Shahid Rajaee Hospital, Qazvin, 
Iran. Patients are referred to this chronic pain clinic by their primary care physicians most often when 
pain persists beyond normal healing time or if pain is recurrent or persistent. Usual care at the chronic 
pain clinic involves patient education (pain management), prescriptions (NSAIDs), physiotherapy 
(exercise, spa therapy). Patients are normally assessed for progress at two month intervals, and 
treatment usually lasts for one year. Patients were eligible to participate in this current study if they 
had a confirmed diagnosis of CLBP (i.e. persistent LBP with or without referred leg pain for at least 3 
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months), were 18 years old or over, and be able to speak and read Persian. Patients were excluded if 
they had any concurrent medical illness (e.g. cardiopulmonary, central nervous system, diabetes, 
intellectual disorder, rheumatic diseases), serious spinal pathology (e.g. fracture, metastatic), and/or 
received spinal surgery. Patients scheduled to attend the outpatient chronic pain clinic were 
approached over a three month period (February 2014 to April 2014), and invited to take part. As this 
is a convenience sample of consecutive patients, the recruitment of patients to this study is not 
aligned to the beginning of treatment for each patient, variation exists on treatment type, treatment 
stage, pain level, and pain impact of the participating patient population. 
 
Patients were contacted by telephone and screened for eligibility by one of the authors (MY). Eligible 
patients were invited to take part in the study at the same time as their scheduled appointment. 
Informed consent was obtained from patients at the time of their appointment, and the patient was 
asked to complete a questionnaire. Subsequently patients were followed up at 6 months.  
 
Measures 
We used a single item self-report global assessment of change question for the patients perceived 
level of recovery at 6 month follow-up 16,17. Such assessments of global recovery have clinical 
relevance, have been found to have high agreement with clinical assessment, and are suitable for 
research due to their brevity and simplicity 18. The question consists of six categories (Completely 
Recovered, Much Better, Better, No Change, Worse, Much Worse) and participants were asked to 
indicate one category. A cut off was chosen for this measure on the basis of clinical utility (e.g. 
identification of subgroup who may benefit from treatment due to no change or worsening outcome 
over time). This variable was collapsed to form two groups: a recovery group (Completely Recovered, 
Much Better, and Better) and a non-recovery group (No change, Worse, Much Worse). 
 
Pain intensity was measured using a visual analogue scale (VAS), and patients were asked to rate 
their pain level at the time of filling out their baseline questionnaire and at 6 month follow up 6,19. For 
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the logistic analysis we based the cut off of 0 or 1 (0mm to 10mm) as an indication of patient recovery 
following previous methodology carried out to identify patient perceived recovery from pain 20,21. 
Information was also collected on the duration of LBP from patients at baseline. Patients were asked 
to signify “How long is it since you had a whole month without any pain?” We categorised the pain 
duration question into two groups for the analysis (6 months or less versus 7 months or more) 
following previous methodology 22,23. 
 
The Pittsburgh Sleep Quality Index (PSQI) was used as a measure of overall sleep quality at baseline 
and at 6 month follow up. The PSQI measures quality and sleep patterns using 7 domains: subjective 
sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbance, sleep medication, and 
daytime dysfunction over the previous month. Scoring uses a 0-3 Likert scale with a global score of 
“5” or greater indicating clinically significant sleep problems; this global score was used as the cut off 
to identify those with sleep problems in this study 24,25. The PSQI has been used previously in 
numerous pain population studies 26,27, and has validation in Persian 28. 
 
Depressive and anxiety symptoms were assessed using the Hospital Anxiety and Depression Scale 
(HADS) at baseline. The HADS includes two scales (depression, anxiety) and each scale comprises 
of 7 items. All items are rated on a Likert-type scale ranging from 0 to 3, with higher scores indicating 
higher symptom levels with scores ranging from 0-21 for each scale 29. The HADS has been 
translated into Iranian (Persian) and has been shown to be valid and reliable in this setting 30. 
 
Patients were asked to provide information regarding demographic characteristics at baseline; age, 
gender, BMI score, and occupational status (working, sick leave, not in work, retired). 
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Analysis 
Descriptive statistics of the percentage proportions, mean, median and inter quartile range were 
presented for all the measures. Initially a prospective model was tested using logistic regression 
producing Odds Ratios (OR) with 95% confidence intervals (95% CI). Those with sleep problems at 
baseline were tested against the reference category of those with no sleep problems at baseline, on 
both self-reported recovery status, and pain intensity outcome, at 6 month follow-up. A two stage 
process was applied to each logistic regression model. Firstly an unadjusted model was created to 
assess the direct relationship between sleep problems and outcome (self-report recovery, pain 
intensity), and then a multivariable model was created including adjustment for baseline depressive 
symptoms, baseline pain intensity (within the patient self-report recovery model only), baseline 
duration of pain, baseline anxiety symptoms, age, gender, BMI, and occupational status. The use of 
an adjusted model gives important indication of the association whilst controlling for potential 
confounding (e.g. effect of depression on the sleep to pain pathway), and the use of both an 
unadjusted and adjusted model allows for inspection of the difference in change due to adjustment 
which may indicate potential mediation or suppression effects. Further exploratory analysis using 
logistic regression models was carried out to assess the full range of experience of sleep problems at 
both baseline and follow-up (prospective and cross sectional associations). Four categories of 
participants were created based on their sleep problem status at both time points (i.e. baseline and 
follow-up). The first category (no sleep problems), were participants who reported no sleep problems 
at baseline and at follow up (used as the reference category within the logistic regression). The 
second category (developing sleep problems) were those participants who reported no sleep 
problems at baseline, but did report sleep problems at follow up. The third category (persistent sleep 
problems) comprised of those participants who reported sleep problems at baseline and at follow up. 
The final category (resolving sleep problems) were those who reported sleep problems at baseline but 
did not report sleep problems at follow up. Data analysis was conducted using IBM SPSS version 
20.0. 
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Results 
In total 807 participants were approached to take part and 761 agreed at baseline representing a 94% 
baseline response rate. At 6 month follow-up 682 participants responded representing an 89% 
response rate. Independent t-tests or chi-square were performed to statistically assess the difference 
in the patent’s age, gender, BMI, depression, anxiety and pain intensity, occupation as well as sleep 
quality between those who responded at 6 months and those who did not respond at 6 month follow-
up, and no differences were found.  
 
Baseline characteristics show a mean age of 41 years with just over 55% of the cohort being male. 
Just over 37% (n= 283) reported their last pain free month within the previous 6 months. At baseline 
48% of the cohort indicated they had experienced sleep problems in the previous month and this rose 
to 67.6% at 6 months follow-up, with only 4.5% of participants reporting resolving sleep problems at 
follow-up. Self-reported recovery at follow-up showed that 58.2% of the cohort indicated they felt 
completely recovered, much better or better compared to how they felt at baseline. For pain intensity 
38.3%% of the cohort reported VAS pain intensity levels at 10mm or below at 6 month follow up. 
Table 1 outlines the characteristics of the cohort. 
 
Patient self-report non recovery 
Table 2 outlines the logistic regression analysis. Results show that the presence of sleep problems at 
baseline significantly increased the odds of poor recovery by approximately 50% at 6 month follow up 
(unadjusted OR 1.52), and this result did not markedly change after adjustment for confounds 
(adjusted OR 1.50). Exploratory analysis using the no sleep problem category (i.e. no reported sleep 
problems at baseline and at follow up) as the reference category within logistic regression analysis 
(see Table 2), show that those with developing sleep problems (i.e. no sleep problems at baseline, 
reported sleep problems at follow up) were almost over 3 times more likely to report non-recovery at 6 
months (unadjusted OR 2.93, 95% CI 1.53, 5.61), and those with persistent sleep problems (i.e. sleep 
problems reported both at baseline and follow-up) were over 3 times more likely to report a non-
recovery (unadjusted OR 3.24, 95% CI 1.63, 6.43), with those who have resolving sleep problems 
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(i.e. sleep problems reported at baseline but none reported at follow-up) having a reduced odds of 
non-recovery (unadjusted OR 0.49, 95% CI 0.31, 0.78). Within the fully adjusted model, results show 
that those with developing sleep problems are just over twice the increase in odds of non-recovery 
(adjusted OR 2.17 95% CI 1.04, 4.52), those with persistent sleep problems were just under 3 times 
the odds of non-recovery (adjusted OR 2.95 95% CI 1.48, 5.88), and those with resolving sleep 
problems were at a reduced odds of non-recovery (adjusted OR 0.50 95% CI 0.31, 0.81) at 6 months.  
 
Patient pain intensity 
Results for pain intensity at follow up as the outcome (cut off set at < 10mm on VAS to indicate 
recovery), show an increase in the odds of non-recovery and higher pain intensity for those with sleep 
problems at baseline with an approximate 2.5 times elevated risk (adjusted OR 2.48, 95% CI 1.62, 
3.70). Further exploratory analysis shows, that compared to those with no sleep problems reported at 
baseline and at follow-up, those with developing sleep problems had an increased risk of non-
recovery for pain intensity by just under 3 times in both unadjusted (OR 2.99 95% CI 1.51, 5.92) and 
adjusted analyses (OR 2.88 95% CI 1.32, 6.31). The effect for those with persistent sleep problems is 
greater with almost 4 times the risk in the unadjusted model (OR 3.73 95% CI 1.92, 7.26) and just 
under 3.5 times the risk within the adjusted model (OR 3.45 95% CI 1.59, 7.46). However those who 
have resolving sleep problems are more likely to recover compared to those with no sleep problems 
at baseline or follow up (see Table 3). 
 
Discussion 
This study tested the relationship of sleep problems on perceived recovery and pain intensity on a 
cohort of LBP patients who attend a pain management clinic. This study tested the prospective 
relationship as well as examined the effect of persistent, developing and resolving sleep problems on 
outcomes. Our findings show support to the study hypotheses: the presence of sleep problems is a 
significant risk factor for non-recovery and pain intensity for those with LBP, also importantly this 
study reports the elevation of risk of poor outcome in those who develop sleep problems, the added 
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strength of risk if the person has persistent sleep problems, as well as a reduction of risk for those 
whose sleep problems resolve over the course of their back pain.  
 
Comparison to the existing literature shows LBP prevalence is comparable within Iran to European 
countries, and other countries worldwide, with similar associated risk factors 1,31,32. Whilst this current 
cohort reports a higher level of pain intensity compared to community based low back pain or chronic 
pain samples 23,33, it does report similar levels to population norms for patients seeking treatments for 
LBP or attending pain management clinics as is the case in this study 34,35. The mean score for the 
PSQI within this current cohort (mean score, 10.5) is generally higher than community dwelling 
individuals (mean rages 4 to 6) 36,37, but this study’s score is within the expected range for individuals 
with pain, comorbidity, sleep problems (e.g. insomnia), and poor health 38,39. In terms of the effect of 
sleep problems, two recent longitudinal studies report similar significant effects to this study in terms 
of the role of the reduction in sleep problems in reducing the reports of pain at follow-up and effect 
sizes reported 40,41. 
 
A major strength of this study is the prospective design which enabled analysis of the predictive 
effects of sleep problems on outcomes in people with LBP. In addition the study has been able to 
describe effects for those who present with sleep problems at baseline, those who subsequently 
develop sleep problems after baseline, and those where sleep problems have resolved at follow-up 
which gives a greater perspective on the timings and sequences of sleep problems and the effects 
they have on patient reported recovery and pain intensity. Another strength of this study is the 
consideration of potential confounds within the analysis. For example depression has a known 
reciprocal relationship with both pain and sleep, with sleep problems being a diagnostic feature of 
depression 12,42, therefore it was important to account for the potential effects of this within the 
analysis. Another important factor accounted for within the regression analysis was the duration of 
back pain prior to the patient entering the study. It was important to control for the effect of duration of 
back pain because research has shown that those with a longer duration of back pain (i.e. chronic) 
have an increased risk of poor outcome in general 43. However this study did not account for other 
important confounds such as caffeine intake, comorbidity, and medication use (analgesia, sleep 
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medication); any one, or all, of these may have influenced the effects reported. There are also 
limitations in terms of the sample. This study recruited a convenience sample of consecutive patients 
attending a chronic pain clinic. Firstly, recruitment was not aligned to the treatment stage of each 
patient (i.e. not every patient was at the beginning of their treatment) and so the trajectory or course 
of pain and sleep will differ with this case mix. This current study’s results on the “developing sleep 
group” give some insight into these effects, however incidence cohort studies (i.e. onset of sleep 
problems within those with pain) will be better placed to give greater detail to the patterns and 
relationships over time. Secondly, severity of symptoms (sleep problems, pain, comorbidity) would be 
likely to be higher within this current chronic pain clinic cohort, compared to general populations or 
primary care populations. Therefore the results in this current study may represent an overestimation 
of the association effects. Nevertheless both primary care and general population samples contain 
sub populations with high levels of pain and sleep problems 7,12, where particular individuals may be 
at similar or higher risk of poor outcome. Whilst the measure of sleep problems used in this study is 
validated, and broadly used in epidemiological studies 24,26, it still only captures a subjective rating of 
sleep quality. The use of objective measures (e.g. polysomnography, actigraphy) may have improved 
the accuracy of our estimates, although this would have proved difficult to apply in large samples such 
as this one. Finally whilst there is clinical utility in the use of “cut points” (e.g. in this current study the 
recovery measure, the pain intensity recovery measure, and the indication of significant sleep 
problems) to potentially identify groups of patients who may benefit from additional treatment, a 
limitation is that this study may have missed changes within individuals, within the sub group 
categories. 
 
The key message derived from the results is that sleep problems significantly predict poor outcome 
for those with LBP who are seeking treatment. The effect sizes for those presenting with sleep 
problems at baseline indicate significant increased risk of poor outcome and pain intensity at follow-
up, and examination of groups accounting for the presence of sleep problems through time show 
larger effects with roughly treble the risk of non-recovery, and presence of pain intensity, due to the 
presence of sleep problems. Moreover the design of this study allowed an examination of the 
development of sleep problems, which showed that almost one quarter of patients develop sleep 
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problems that associate with poor outcome, whilst in comparison the proportion that resolved was 
relatively small. This finding highlights not only a need to evaluate and perhaps address sleep 
problems in the presenting patient, but also to be aware of the potential risk to patients of developing 
sleep problems, and so monitoring and assessment of sleep problems may be beneficial. A further 
noticeable finding, albeit in a small proportion, is that those who report that their sleep problems have 
resolved are more likely to report recovery, compared to those who have not reported sleep problems 
at all. This may reflect the intrinsic link between pain and sleep 10, and may suggest that to address 
both within treatment may have an additive positive effect on recovery, over and above targeting pain 
or sleep independently. Indeed early evidence is now emerging on the benefits of targeting sleep 
problems in those with pain; a recent meta-analysis by Tang et al (2015) considered evidence of non-
pharmacological Randomised Controlled Trial interventions targeted at sleep for adults who report 
long term pain 44. Results show significant reductions in sleep problems, fatigue, and pain at post 
treatment.  
 
Conclusion 
This study of patients with LBP has shown an increase in risk of poor outcomes in those with LBP 
who report sleep problems. Clinicians may wish to consider treatment options that involve addressing 
sleep problems as part of their treatment. 
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Legends 
 
Table 1 Cohort characteristics 
Table 2. Logistic regression (LR) with 95% Confidence Intervals (95% CI) for relationship of 
sleep problems with non-recovery for those with low back pain. 
 
Table 3.Logistic regression (LR) with 95% Confidence Intervals (95% CI) for relationship of 
sleep problems with pain intensity for those with low back pain. 
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Table 1 Cohort characteristics 
Baseline 
Characteristic Number (%) mean (SD) Interquartile range 
    
Age  41.15 (12.24) 16 
Gender (Male) 414 (55.4%)   
PSQI Sleep Quality proportion (sleep problems) and scale 
score 365 (48.0%) 10.5 (3.5) 5.0 
VAS Pain Intensity  7.2 (2.31) 5.0 
Depressive symptoms 7.8 (4.2) 5.0 
Anxiety symptoms  11.8 (5.2) 8.0 
BMI score  27.8 (6.3) 7.4 
Last pain free episode of back pain over 7 months 478 (62.8%)   
Occupational status  
working 285 (37.5%)  
sick leave 151 (19.8)   
not employed 220 (28.9%)   
Retired 105 (13.8%)  
6 month follow-up
PSQI Sleep Quality proportion (sleep problems) and scale 
score 461 (67.6%) 9.32 (3.1) 5.0 
Sleep problem categories  
No sleep problems 190 (27.9%)   
Developing sleep problems 165 (24.2%)   
Persistent sleep problems 296 (43.4%)  
Resolved sleep problems 31 (4.5%)  
Self-reported recovery    
Completely recovered 143 (18.8%)   
Much better 91 (11.9%)  
better 209 (27.5%)  
No change 58 (7.6%)   
Worse 114 (15.0%)   
Much worse 67 (8.8%)  
Missing 79 (10.4%)   
VAS Pain Intensity  5.1 (2.4) 5.0 
Recovered (VAS < 10mm) 261 (38.3%)  
Non Recovery (VAS > 10mm) 421 (61.7%)  
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Table 2. Logistic regression Odds Ratio (OR) with 95% Confidence Intervals (95% CI) for 
relationship of sleep problems with non-recovery for those with low back pain. 
 
Sleep problem status Unadjusted OR 
(95% CI) 
Adjusted* OR (95% 
CI) 
 
No sleep problems Reference category Reference Category 
Sleep problems 1.52 (1.10, 2.08) 1.50 (1.09, 2.17)
Exploratory baseline and follow-up group analysis 
No sleep problems (none at baseline, none at follow-up) Reference category Reference Category 
Developing sleep problems (none at baseline, present at follow-up) 2.93 (1.53, 5.61) 2.17 (1.04, 4.52) 
Persistent sleep problems (present at baseline and follow-up) 3.24 (1.63, 6.43) 2.95 (1.48, 5.88) 
Resolving sleep problems (present at baseline, not present at follow-up) 0.49 (0.31, 0.78) 0.50 (0.31, 0.81) 
*Baseline adjustment for: pain intensity, depressive and anxiety symptoms, age, gender, occupational status, and duration of back pain 
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Table 3.Logistic regression (LR) with 95% Confidence Intervals (95% CI) for relationship of 
sleep problems with pain intensity for those with low back pain. 
 
 
Sleep problem status Unadjusted OR 
(95% CI) 
Adjusted* OR (95% 
CI) 
 
No sleep problems Reference category Reference Category 
Sleep problems 2.69 (1.72, 4.11) 2.48 (1.62, 3.70) 
Exploratory baseline and follow-up group analysis 
No sleep problems (none at baseline, none at follow-up) Reference category Reference Category 
Developing sleep problems (none at baseline, present at follow-up) 2.99 (1.51, 5.92) 2.88 (1.32, 6.31) 
Persistent sleep problems (present at baseline and at follow-up) 3.73 (1.92, 7.26) 3.45 (1.59, 7.46) 
Resolving sleep problems (present at baseline, not present at follow-up) 0.46 (0.25, 0.87) 0.49 (0.26, 0.93)
*Baseline adjustment for: pain intensity, depressive and anxiety symptoms, age, gender, occupational status, and duration of back pain 
 
 
